🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, double-blind, placebo controlled study will involve 600 he...
Status
Completed
Location
Retina Consultants of Southern Colorado
Start Date
2017-10-05
Trial ID
NCT03320174
Treatments Being Tested
This study is a phase 2b, placebo controlled, randomized, blinded study of ...
Status
Completed
Location
Multiple Locations
Start Date
1997-05
Trial ID
NCT02491606
Treatments Being Tested
Tafenoquine was recently approved by regulatory authorities in the USA and ...
Status
Recruiting
Location
Mahidol Oxford Tropical Medicine Research Unit (MORU), Cambodia
Start Date
2024-07-22
Trial ID
NCT04704999
A clinical study to assess the efficacy and safety of oral tafenoquine comp...
Status
Unknown
Location
Multiple Locations
Start Date
2023-08-01
Trial ID
NCT05947812
Treatments Being Tested
This was a placebo controlled, randomised, double-blind, double-dummy study...
Status
Completed
Location
Multiple Locations
Start Date
2000-05
Trial ID
NCT02488980
Treatments Being Tested
This was a randomised, double-blind, placebo-controlled study to compare th...
Status
Completed
Location
Multiple Locations
Start Date
1998-08
Trial ID
NCT02488902
Treatments Being Tested
A clinical study to assess the efficacy and safety of oral tafenoquine comp...
Status
Completed
Location
Deluxe Health Center LLC
Start Date
2021-02-19
Trial ID
NCT04533347
Treatments Being Tested
FLAME is an open-label cluster-randomized controlled trial that aims to det...
Status
Recruiting
Location
Asociación Civil Selva Amazónica
Start Date
2024-10-14
Trial ID
NCT05690841
Treatments Being Tested
In 2018, the U.S. Food and Drug Administration (FDA) and the Australian The...
Status
Unknown
Location
108 Military Central Hospital
Start Date
2022-05-10
Trial ID
NCT05203744
Treatments Being Tested
The purpose of this expanded access protocol is to offer a potentially effe...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06478641
Treatments Being Tested